Weight changes with treatment of type 2 diabetes with pioglitazone, metformin and gficlazide

被引:0
|
作者
Belcher, G
Edwards, G
Urquhart, R
Eckland, D
Johns, D
Tan, MG
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A111 / A111
页数:1
相关论文
共 50 条
  • [1] Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes
    Gupta, Alok K.
    Bray, George A.
    Greenway, Frank L.
    Martin, Corby K.
    Johnson, William D.
    Smith, Steven R.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2010, 24 (05) : 289 - 296
  • [2] Cardiovascular effects of treatment of type 2 diabetes with pioglitazone, metformin and gliclazide
    Belcher, G
    Lambert, C
    Goh, KL
    Edwards, G
    Valbuena, M
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (09) : 833 - 837
  • [3] Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes
    Belcher, G
    Lambert, C
    Edwards, G
    Urquhart, R
    Matthews, DR
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 70 (01) : 53 - 62
  • [4] Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
    Holland, Daniel Q.
    Neumiller, Joshua J.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 277 - 288
  • [5] Enhancing Diabetes Treatment: Comparing Pioglitazone/Metformin with Dapagliflozin Versus Basal Insulin/Metformin in Type 2 Diabetes
    Lin, Yi
    Shi, Jianxia
    Yu, Xuemei
    Sun, Jiao
    Lixia, Suo
    Dou, Jiaqing
    Zhang, Min
    Li, Xiaohua
    Tian, Zhufang
    Deng, Hongyan
    Feng, Bo
    Su, Qing
    Peng, Yongde
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 1795 - 1808
  • [6] Effects of pioglitazone and metformin on blood pressure in type 2 diabetes
    Lawrence, JM
    Reid, J
    Taylor, GJ
    Stirling, C
    Reckless, JPD
    ATHEROSCLEROSIS, 2003, 169 (02) : 357 - 357
  • [7] Combination therapy with pioglitazone and metformin in patients with type 2 diabetes
    Egan, J
    Rubin, C
    Mathisen, A
    DIABETES, 1999, 48 : A117 - A117
  • [8] Changes in liver tests during 1-year treatment of patients with Type 2 diabetes with pioglitazone, metformin or gliclazide
    Belcher, G
    Schernthaner, G
    DIABETIC MEDICINE, 2005, 22 (08) : 973 - 979
  • [9] Combining pioglitazone with a sulphonylurea or metformin in the management of type 2 diabetes
    Hanefeld, M
    Göke, B
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2000, 108 : S256 - S266
  • [10] Pioglitazone for the treatment of type 2 diabetes
    Nabrdalik, Katarzyna
    Cichocka, Edyta
    Zywiec, Joanna
    Chodkowski, Artur
    Gumprecht, Janusz
    CLINICAL DIABETOLOGY, 2014, 3 (04): : 176 - 180